Page 11 - Service Testing News Today

Viking Therapeutics has a stock offering starting at $85 — a discount from its Wednesday closing price of $94.50.

By Josh Beckerman Shares of vTv Therapeutics more than doubled after the company raised $51 million in a private placement, which will be used to fund the...

Viking posted positive results from a mid-stage trial of its GLP-1 drug.

Viking posted positive results from a mid-stage trial of its GLP-1 drug.

Patients saw ‘significant’ reductions in body weight during a study of a weight-loss drug developed by Viking Therapeutics.

Viking posted positive results from a mid-stage trial of its GLP-1 drug.

/PRNewswire/ -- The global EMC shielding and test equipment market is expected to be valued at USD 8.4 billion in 2024 and is projected to reach USD 11.3...

RAPT Therapeutics shares dropped more than 60% premarket on Tuesday after the company said regulators have hit pause on two clinical trials of its...

By Colin Kellaher Shares of RAPT Therapeutics plummeted more than 65% in premarket trading Tuesday after a serious adverse event prompted the U.S. Food and...

Investors looking for signs the FDA will let more patients use Sarepta Therapeutics’ Duchenne muscular dystrophy treatment got exactly that.